| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J2777 |
Injection, faricimab-svoa, 0.1 mg |
1,395 |
1,306 |
$1.22M |
| 67028 |
Intravitreal injection of a pharmacologic agent |
16,644 |
15,489 |
$1.07M |
| J0178 |
Injection, aflibercept, 1 mg |
776 |
730 |
$562K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
10,120 |
9,804 |
$426K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
13,452 |
13,334 |
$391K |
| 92134 |
|
26,700 |
25,808 |
$391K |
| J9035 |
Injection, bevacizumab, 10 mg |
7,603 |
7,099 |
$289K |
| J2778 |
Injection, ranibizumab, 0.1 mg |
849 |
819 |
$233K |
| 92250 |
|
7,177 |
7,061 |
$154K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
2,116 |
2,106 |
$148K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
804 |
801 |
$66K |
| 76512 |
|
3,236 |
2,657 |
$49K |
| 67228 |
|
107 |
88 |
$27K |
| 92235 |
|
420 |
416 |
$25K |
| 92226 |
|
105 |
53 |
$423.49 |
| J7999 |
Compounded drug, not otherwise classified |
59 |
55 |
$273.20 |
| 92225 |
|
22 |
12 |
$137.12 |
| G9744 |
Patient not eligible due to active diagnosis of hypertension |
312 |
295 |
$0.00 |
| 2026F |
|
322 |
304 |
$0.00 |
| 2022F |
|
324 |
306 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
57 |
55 |
$0.00 |
| G9974 |
Dilated macular exam performed, including documentation of the presence or absence of macular thickening or geographic atrophy or hemorrhage and the level of macular degeneration severity |
13 |
13 |
$0.00 |
| 2024F |
|
322 |
304 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
12 |
12 |
$0.00 |
| 5010F |
|
16 |
15 |
$0.00 |
| 1036F |
|
394 |
376 |
$0.00 |
| 4177F |
|
50 |
49 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
130 |
125 |
$0.00 |
| 2019F |
|
15 |
14 |
$0.00 |